SNOA
#4867
Sonoma Pharmaceuticals, Inc. - Common Stock
1.3 1 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.50%
Monthly Change
+11.02%
6 month change
-57.19%
Year Change
-52.71%
Previous Close
1.3 3
Open
1.3 1
Low
1.2 8
High
1.3 4
Volume
25
Financials
- Market Capitalization 6.27 M
- Employee 260
- Founded 1999
- CEO N/A
- Website www.sonomapharma.com
- Headquarter Delaware, United States
- FIGI BBG000M75YR0
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.13
Price to sales ratio
0.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4535 |  BFRI Biofrontera Inc. - Common Stock | 1.49 USD | -2.61% | -0.67% | +33.04% | +71.26% | 22.13 M USD | ||
| 4831 |  AKAN Akanda Corp. - Common Shares | 4.03 USD | -4.73% | +1.77% | -32.83% | +2.54% | 7.99 M USD | ||
| 4914 |  YCBD cbdMD, Inc. Common Stock | 0.50 USD | 0.00% | -1.96% | -1.96% | -29.58% | 5.60 M USD | ||
| 4954 |  SBFM Sunshine Biopharma Inc. - Common stock | 1.24 USD | -2.36% | +7.83% | -13.29% | +5.08% | 4.81 M USD |
Frequently asked questions about Sonoma Pharmaceuticals, Inc. Common Stock
What is the Sonoma Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is 1.31. Over the past 24 hours, the stock has changed by -1.50%. Follow the SNOA chart for real-time price dynamics.
What is the stock ticker of Sonoma Pharmaceuticals, Inc. Common Stock?
Sonoma Pharmaceuticals, Inc. Common Stock trades under the ticker SNOA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sonoma Pharmaceuticals, Inc. Common Stock stock going up?
SNOA has changed by -2.96% over the last week, +11.02% over the last month, and -52.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Sonoma Pharmaceuticals, Inc. Common Stock?
Sonoma Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 6.27 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Sonoma Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Sonoma Pharmaceuticals, Inc. Common Stock reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Sonoma Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Sonoma Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 6.41 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Sonoma Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Sonoma Pharmaceuticals, Inc. Common Stock reported net income of -330 K for the last quarter. The previous quarter showed -581 K, which means net income changed by +43.20%.
How many employees does Sonoma Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Sonoma Pharmaceuticals, Inc. Common Stock has 260 employees. Workforce size can provide additional context about the company's scale and operations.
What is Sonoma Pharmaceuticals, Inc. Common Stock EBITDA?
Sonoma Pharmaceuticals, Inc. Common Stock EBITDA is -8 000, and its EBITDA margin is -0.12%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Sonoma Pharmaceuticals, Inc. Common Stock stock?
You can buy Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sonoma Pharmaceuticals, Inc. Common Stock stock?
Investing in Sonoma Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SNOA chart and related analysis on metatrader.com as part of your research.